✦ LIBER ✦

PM001 Randomized Placebo Controlled Study To Assess Valsartan Efficacy In Preventing Left Ventricle Remodeling In Patients With Dual Chamber Pacemaker - Rationale of The Trial

✍ Scribed by Tomasik, Andrzej; Jachec, Wojciech; Kawecki, Damian; Wojciechowska, Celina; Kubiak, Grzegorz; Wozniak, Katarzyna; Bialkowska, Beata; Kalarus, Zbigniew; Nowalany-Kozielska, Ewa

Book ID: 122892367
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 75 KB
Volume: 9
Category: Article
ISSN: 2211-8160
DOI: 10.1016/j.gheart.2014.03.1427

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The MINERVA study design and rationale:

The MINERVA study design and rationale: A controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias

✍ Reinhard C. Funck; Giuseppe Boriani; Antonis S. Manolis; Helmut Püererfellner; L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Rationale and design of a randomized con

Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure—the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study

✍ Cecilia Linde; Michael Gold; William T. Abraham; Jean-Claude Daubert 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Rationale and design of the RIACT–study:

Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial

✍ Lena Schiffer, Mario Schiffer, Saskia Merkel, Anke Schwarz, Michael Mengel, Chri 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 454 KB

The rationale and design of the FORωARD

The rationale and design of the FORωARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation

✍ Alejandro Macchia; Sergio Varini; Hugo Grancelli; Daniel Nul; Nicolas Laffaye; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 213 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB

Rationale and design of the EMBRACE STEM

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

✍ Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra; Brown, David A.; Czyz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB